Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.
Ontology highlight
SUBMITTER: Mirgh S
PROVIDER: S-EPMC12783642 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA